h/t Gilman.
Thursday, June 10, 2010
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
IN VIVO: The Business & Medicine Report
Pages
Follow Us ...
| ||||||||
Headlines from 'The Pink Sheet' DAILY
Contributors
Labels
About This Blog
Welcome to The IN VIVO Blog, home of daily commentary on recent developments in biopharmaceutical business development, R&D, financing, marketing, and policy. Join us for discussion in the comments, or contact us via email.
Click These Links!
Blog Archive
-
▼
2010
(261)
-
▼
June
(19)
- This Charming CEO
- VEGF & Colorectal Cancer: How Do You Know When to ...
- While You Were Getting Eliminated
- Deals of the Week in a Parallel Dimension
- While You Were Calling the Old Man
- Deals of the Week Goes Hollywood
- Managed Care Has More Faith in the Big Pharma Mode...
- Financings of the Fortnight Follows the Money Wher...
- Pfizer’s Adverse Event Reporting Warning Letter: T...
- Health Care Reform: New Fees are New Factor For Pa...
- While You Were Drawing
- Deals of the Week Screams ¡GOOOOOOOOOLLLLLLL!
- And Now, It's Time for a Rap About Stem Cells
- Guest Post: The Next Feeding Frenzy? VCs Rush Towa...
- Transparency in Action: FDA Comments on Pirfenidone
- Financings of the Fortnight Looks for Its Shadow
- Turn Out the Lights and Go Home, the Cleveland Cli...
- Drug Safety 2010: Nissen Meets With FDA Leadership...
- While You Were Perfect
-
▼
June
(19)
Footer
IN VIVO: The Business & Medicine Report
© Copyright 2014 Informa plc.
Informa Business Information. All Rights Reserved.
www.pharmamedtechbi.com
1 comment:
I think Jonathan once did improv and it looks like he's found a way to combine all his talents! What grad student wouldn't want to work in his lab?!
Post a Comment